348 related articles for article (PubMed ID: 18849523)
21. A complex karyotype, including a three-way translocation generating a NUP98-HOXD13 transcript, in an infant with acute myeloid leukemia.
Hidaka E; Tanaka M; Matsuda K; Ishikawa-Matsumura M; Yamauchi K; Sano K; Honda T; Wakui K; Yanagisawa R; Nakazawa Y; Sakashita K; Shiohara M; Ishii E; Koike K
Cancer Genet Cytogenet; 2007 Jul; 176(2):137-43. PubMed ID: 17656257
[TBL] [Abstract][Full Text] [Related]
22. Identification of Taxus microRNAs and their targets with high-throughput sequencing and degradome analysis.
Hao DC; Yang L; Xiao PG; Liu M
Physiol Plant; 2012 Dec; 146(4):388-403. PubMed ID: 22708792
[TBL] [Abstract][Full Text] [Related]
23. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
[TBL] [Abstract][Full Text] [Related]
24. Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells.
Hara T; Schwieger M; Kazama R; Okamoto S; Minehata K; Ziegler M; Löhler J; Stocking C
Oncogene; 2008 Jun; 27(27):3865-9. PubMed ID: 18223676
[TBL] [Abstract][Full Text] [Related]
25. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).
Taketani T; Taki T; Shibuya N; Kikuchi A; Hanada R; Hayashi Y
Cancer Res; 2002 Aug; 62(16):4571-4. PubMed ID: 12183408
[TBL] [Abstract][Full Text] [Related]
26. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
Reader JC; Leng Q; Rassool FV; Ning Y
Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
[TBL] [Abstract][Full Text] [Related]
27. Cloning and mapping of the MEIS1 gene, the human homolog of a murine leukemogenic gene.
Smith JE; Bollekens JA; Inghirami G; Takeshita K
Genomics; 1997 Jul; 43(1):99-103. PubMed ID: 9226379
[TBL] [Abstract][Full Text] [Related]
28. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
[TBL] [Abstract][Full Text] [Related]
29. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
Ahmed FE
Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
31. Hox genes: from leukemia to hematopoietic stem cell expansion.
Abramovich C; Pineault N; Ohta H; Humphries RK
Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703
[TBL] [Abstract][Full Text] [Related]
32. NUP98 dysregulation in myeloid leukemogenesis.
Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease.
Deveau AP; Forrester AM; Coombs AJ; Wagner GS; Grabher C; Chute IC; Léger D; Mingay M; Alexe G; Rajan V; Liwski R; Hirst M; Steigmaier K; Lewis SM; Look AT; Berman JN
Leukemia; 2015 Oct; 29(10):2086-97. PubMed ID: 26017032
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia.
Ye J; Luo D; Yu J; Zhu S
Hematology; 2019 Dec; 24(1):487-491. PubMed ID: 31210592
[TBL] [Abstract][Full Text] [Related]
35. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.
Lin XC; Xu Y; Sun GP; Wen JL; Li N; Zhang YM; Yang ZG; Zhang HT; Dai Y
Int J Oncol; 2016 Jun; 48(6):2367-80. PubMed ID: 27082628
[TBL] [Abstract][Full Text] [Related]
36. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
38. The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia.
Rio-Machin A; Gómez-López G; Muñoz J; Garcia-Martinez F; Maiques-Diaz A; Alvarez S; Salgado RN; Shrestha M; Torres-Ruiz R; Haferlach C; Larráyoz MJ; Calasanz MJ; Fitzgibbon J; Cigudosa JC
Leukemia; 2017 Sep; 31(9):2000-2005. PubMed ID: 28630438
[No Abstract] [Full Text] [Related]
39. Nuclear, not cytoplasmic, PKR maneuvers in AML.
Oshima M; Iwama A
Blood; 2015 Sep; 126(13):1523-4. PubMed ID: 26405214
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Transcriptome Profiling of Cryptic
Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
